Patients Taking PARP Inhibitor Survive Ovarian Cancer Longer with Fewer Complications

dna strand

Ovarian cancer is one of the deadliest forms of women’s cancer, with a five-year survival rate of 47.4 percent. The standard of care for first-line treatment is platinum- and taxane-based chemotherapy, which results in high initial response rates.

Read More

Genetic Association with Recurrent Miscarriage May Guide Further Treatment

diagram of chromosomal rearrangments
Left: Circos plot showing a complex chromosomal rearrangement involving four chromosomes (color lines) detected by low-pass genome sequencing.
Right: Karyotype showing a chromosomal rearrangement involving the interchange of fragments of different chromosomes.

For couples with recurrent miscarriage (RM), the condition remains unexplained in about 40 to 60 percent, even after costly testing. Chromosomal abnormalities—rearrangements of large chunks of DNA—in the genomes of one or both individuals trying to conceive are thought to be among the major genetic causes of RM. But routine chromosome analysis (karyotyping) can currently detect these abnormalities in only about 1 in 50 couples.

Read More

Preserving Fertility with Minimally Invasive Myomectomy

3D illustration of surgical robot on white background

Uterine fibroids are highly prevalent in women over 35. As more women delay childbearing, techniques to remove uterine fibroids (leiomyomas) while also preserving fertility are of increasing importance.

Read More

Artificial Intelligence to Automate Drug Infusions for Safer C-Sections

Vesela Kovacheva, MD, PhD, was not thinking about her work as an obstetric anesthesiologist when she opened an article about artificial intelligence (AI) in 2017, expecting to learn about self-driving cars and the algorithms behind online shopping.
Read More

Postpartum Transition Clinic for Hypertensive Pregnancies

Strong evidence that now connects preeclampsia with long-term maternal cardiovascular risks raises new questions for obstetricians (OBs):  What is the best way to care for women after preeclampsia? And, what postpartum care and support might help women minimize immediate and long-term risks?
Read More

Inventing a “Better Way”: Developing Devices to Improve Minimally Invasive Gynecologic Surgery

Jon I. Einarsson, MD, MPH
Jon I. Einarsson, MD, MPH, didn’t set out to be an inventor. Chief of the Division of Minimally Invasive Gynecologic Surgery at Brigham and Women’s Hospital, Einarsson is a champion of minimally invasive approaches for their benefits to patients. But as a teacher and mentor, he knows that some techniques that benefit patients are slightly more challenging technically for trainees and others to master.
Read More

Restoration of Infertility Using Patient-Specific Stem Cells

For women who want their own biological children, a diagnosis of infertility due to a lack of viable eggs can be devastating. Ovarian failure in women can have many causes, including aging, autoimmune disease and exposure to radiation therapy and certain chemotherapy drugs.
Read More

Reducing Long-Term CV Risks after Preeclampsia through Online Intervention and Communication

An online intervention program for women who recently had preeclampsia has produced insight into how to reduce their future risks of cardiovascular disease.

Read More

Novel SEQaBOO Study of Newborn Hearing Loss Foretells Role for Obstetricians in Genomic Medicine

The ear of a newborn baby only a few weeks old.As genetic and genomic sequencing become incorporated into newborn screening for hearing loss, patients may look to obstetricians for guidance on genetic testing decisions.

Auditory screening of newborns, mandated by most states in recent decades, now reaches an estimated 98 percent of newborns in the United States and has significantly reduced the average age for identifying congenital deafness. But adding genetic testing could drive more accurate diagnosis and personalized management during infancy’s critical window when the brain’s speech and language center is developing rapidly.
Read More

Creating Healthy Families, One Embryo at a Time

embryo in a petri dish, Catherine Racowsky's labPredicting which IVF embryos are most likely to produce a healthy pregnancy is an ongoing challenge in the field. For embryologist Catherine Racowsky, PhD, it is a theme across her varied work as director of the IVF Lab at Brigham and Women’s Hospital, as a researcher of new techniques to find the healthiest embryos and as incoming president of the American Society of Reproductive Medicine.

Read More